The Innovation Paradox

Demand for health innovation is rising rapidly as health systems become increasingly stretched. As demand increases, the ability to introduce innovation safely and at pace becomes more constrained.

The true test of innovation is adoption that can be safely scaled at pace.  Yet many high-potential products, programmes and pathways stall. 

Even where approvals are secured, real-world uptake falters because leaders discover, often late, that:

• system interdependencies and complexities were not fully understood
• governance, workforce, flow, finance or data constraints were underestimated
• engagement of health service partners was assumed rather than secured
• political or delivery risks were not visible at the point of commitment

By the time these issues become visible, credibility has been damaged, investment has been committed, resistance has formed, and opportunities to mitigate risk have narrowed.

This failure mode is common, predictable and avoidable.

The opportunity lies in identifying system impacts, risks and benefits early, before commitments are made, while meaningful options to adapt remain.

This is Health System Adoption Diligence.